Abstract: Perfluoropolyethereal compounds having polycarbonate structure, and general formula: ##STR1## wherein c is an integer comprised between 0 and 10, preferably between 0 and 3,n is an integer from 2 to 1,000, extremes included,Rf is a poly-fluorooxyalkylenic chain, having number average molecular weight (Mn) comprised between 500 and 10,000.

Abstract: 1) Disclosed herein are new fluorine-containing compounds having polyacetalic structure, of general formula:[Rf.sub.m --CH.sub.2 O(CH.sub.2 O).sub.c --CH.sub.2 --.brket close-st..sub.n (I)where:Rf=a perfluorooxyalkylene chain having Mn from 500 to 5,000;m=4-25;c=1-10;n=2-100.2) A process for preparing them which comprises carrying out the polycondensation of diols having formula:HORfOH (II)with formaldehyde, in mass or in the presence of solvents, in an acid medium. The compounds of formula (I) can be oligomeric compounds (polymerization degree x.sub.n from 2 to about 20) or polymeric compounds (x.sub.n from about 20 to about 100). They exhibit a high stability to heat and to chemical agents, and Tg values slightly different from the ones of the diols utilized for preparing them.

Abstract: 1) New fluorine-containing compounds having polyacetalic structure, of general formula:(I)[Rf.sub.m --CH.sub.2 O(CH.sub.2 O).sub.c --CH.sub.2 ].sub.nwhere:Rf=a perfluorooxyalkylene chain having Mn from 500 to 5,000;m=4-25;c=1-10;n=2-100.2) A process for preparing them, which comprises carrying out the polycondensation of diols having formula:(II) HORfOHwith formaldehyde, in mass or in the presence of solvents, in an acid medium. The compounds of formula (I) can be oligomeric compounds (polymerization degree x.sub.n from 2 to about 20) or polymeric compounds (x.sub.n from about 20 to about 100). They exhibit a high stability to heat and to chemical agents, and Tg values slightly different from the ones of the diols utilized for preparing them.

Abstract: The present invention concerns tetraethylene glycol monoesters with 2-arylpropionic acids (known as anti-inflammatory agents). Said esters, while being endowed with the characteristics of low toxicity and gastric injuring effects shown by the related acids, differ advantageously from the latter because their anti-inflammatory activity is much more prolonged, and their bioavailability markedly better.

Abstract: The present invention concerns diesters of polyethylene glycols (with n ranging between 4 approximately and 100 approximately) with 2-arylpropionic acids (known as anti-inflammatory agents). These esters, while possessing all the characteristics of low toxicity and gastric injuring effects shown by the related acids, differ advantageously from the latter because their anti-inflammatory activity is much more prolonged, and their bio-availability markedly better.